Trial Profile
Sunitinib malate in advanced alveolar soft part sarcoma (ASPS)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Alveolar soft part sarcoma
- Focus Therapeutic Use
- 21 Jul 2015 New trial record
- 02 Jun 2015 Final results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.